Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP).
Purity:
>99.0%
CAS Number:
[915810-67-2]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted